Glucose monitoring specialist Dexcom announced it received FDA clearance for its G7 15 Day continuous glucose monitoring (CGM) system for people 18 and older with type 1, type 2 and gestational diabetes.
G7 15 Day, scheduled to launch in the second half of this year, will have a 15.5-day wear time (including a 12-hour grace period) and last 15% longer than Dexcom G7, according to the company. ...
Editor's note: This article has been updated with clarifying comments from Dexcom.
Glucose-monitoring specialist Dexcom made several announcements this year, including receiving FDA clearance for its over-the-counter continuous glucose monitoring (CGM) solution Stelo, G7's expanded capabilities to connect directly to the Apple Watch and, most recently, its $75 million investment in and strategic...
Continuous glucose monitoring system maker Senseonics has won FDA approval for its Eversense E3, which can be used to measure glucose levels in adults with diabetes for up to six months.
The system works using a sensor that is implanted just under the skin by a healthcare provider. A transmitter worn over the sensor, on top of the skin, receives glucose data, provides vibratory alerts and...
Third-party digital health companies can now integrate Dexcom’s continuous glucose monitoring data into their platforms and devices in real-time thanks to a new FDA clearance for the company’s Partner Web APIs.
The data integration capabilities are available to companies on an invite-only basis. So far, wearable device-maker Garmin and chronic-condition-management company Livongo have entered the...
Abbott’s continuous glucose monitoring system, the FreeStyle Libre 2, has been approved in Canada for adults and children four years and older with diabetes.
The FreeStyle Libre 2 system continuously measures glucose data every minute and can automatically alert users when their glucose is high or low without needing to scan the sensor.
It is worn on the back of the user’s upper arm for up to 14...
This morning continuous glucose monitor (CGM) startup Movano Inc. exited stealth with the news of $10 million bridge funding round headed by Tri-Valley Ventures. Taken alongside its prior investments, the company said it has now raised $27 million since its founding in 2018.
WHAT THEY DO
Movano is developing a connected CGM wearable that doesn't require the user to break the skin with a needle or...
UnitedHealth Group announced plans this morning to distribute a device-driven diabetes management model to 230,000 employer-sponsored members with Type 2 diabetes at no additional cost.
The pilot program, called Level2 by UnitedHealthcare, provides members with a Dexcom G6 continuous glucose monitor (CGM) that connects to their smartphone, a Fitbit activity tracker, personalized coaching and...
The American Diabetes Association's 80th Scientific Sessions kicked off this weekend, and a handful of diabetes management device-makers and service providers highlighted new data as part of the virtual clinical conference. Read on for summaries of the studies and findings, as well as links to the online abstracts.
Onduo
Verily-backed diabetes management service Onduo, which combines a mobile app...
One of the biggest digital health success stories of the two decades is in the diabetes space, especially the continuous glucose monitor (or CGM). The first CGM was approved by the FDA in 1999, but in the last decade we've seen CGMs become smaller, longer lasting and more comfortable, and we've seen huge strides in datasharing as CGM-phone connectivity went from novelty to commodity.
Dexcom has...
Dexcom continuous glucose monitor users and their caregivers found themselves in the dark this weekend when a key monitoring feature ceased to function with little to no warning.
The feature, called Dexcom Follow, transmits an alert when a CGM user’s blood sugar reaches a dangerous level and is often used by parents monitoring their children’s condition. When unexpected issues brought down the...
_5.jpg?itok=6UqnU5Jo "An older man wearing headphones checking his smartphone")
